Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Anca Lavinia Cianga has a total of 54 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Beyond the Steroid Trial: A Scoping Review of Biomarkers for Pediatric Nephrotic Syndrome

    by Tudor-Ilie Lazaruc, Anca-Lavinia Lazaruc-Postolache, Iuliana-Magdalena Starcea, Roxana-Alexandra Bogos, Maria-Adriana Mocanu, Madalina-Andreea Beldie, Ingrith-Crenguta Miron

    Background: Pediatric idiopathic nephrotic syndrome (INS) is classified primarily by corticosteroid response, delaying identification of steroid-resistant disease and exposing children to unnecessary treatment toxicity. Novel biomarkers could enable earlier biological stratification and treatment guidance. Objectives: The study aimed to map available evidence on candidate biomarkers in pediatric INS published since 2020, with emphasis on anti-nephrin autoantibodies and their potential for clinical translation. Data Sources: PubMed/MEDLINE and Web of Science Core Collection (January 2020–October 2025), with a supplementary verification search in Scopus and Embase and manual reference screening. Eligibility Criteria: Original studies reporting circulating, urinary, or tissue-based biomarkers in children aged 0–18 years with idiopathic NS, with outcomes related to diagnosis, treatment response, relapse prediction, or monitoring. Studies in adults only, secondary NS, or animal models were excluded. Results: After screening, 34 studies met the eligibility criteria and were included, grouped into five categories: autoantibodies, urinary markers, immune cell signatures, cytokines/chemokines, and exploratory markers (metabolomics, extracellular vesicles, lipid profiles, microRNAs). Anti-nephrin IgG emerged as the most mechanistically informative marker, with seroprevalence declining across phenotypes (SSNS 68%, SDNS 28%, non-genetic SRNS 14%, genetic SRNS 2%) and positivity predicting response to intensified immunosuppression. Of the candidates reviewed, urinary NGAL and peripheral B-cell subset monitoring are the most readily implementable with existing laboratory infrastructure. Conclusions: Pediatric INS encompasses a spectrum of immune-mediated podocytopathies that may soon be distinguishable by emerging biomarker profiles. Anti-nephrin autoantibodies provide the strongest mechanistic evidence for an autoimmune podocytopathy.

  • Open Access

    Correction: Iațentiuc et al. From Ototoxicity to Otoprotection: Mechanism and Protective Strategies in Cisplatin Therapy. Pharmaceuticals 2025, 18, 1543

    by Andreea Iațentiuc, Sebastian Romică Cozma, Otilia Elena Frăsinariu, Ingrith Crenguța Miron, Iustin Mihai Iațentiuc, Lucia Corina Dima-Cozma, Raluca Olariu, Anca Postolache, Ana-Maria Laura Buga, Alexandru Stingheriu, et al.

  • Open Access

    From Ototoxicity to Otoprotection: Mechanism and Protective Strategies in Cisplatin Therapy

    by Andreea Iațentiuc, Sebastian Romică Cozma, Otilia Elena Frăsinariu, Ingrith Crenguța Miron, Iustin Mihai Iațentiuc, Lucia Corina Dima-Cozma, Raluca Olariu, Anca Postolache, Ana-Maria Laura Buga, Alexandru Stingheriu, et al.

    Although cisplatin plays a vital role in chemotherapy protocols, its impact on hearing should not be overlooked. The ototoxic effects of cisplatin can lead to hearing loss. Childhood hearing loss can significantly impact various aspects of development. Understanding the mechanism of cisplatin-induced ototoxicity is crucial due to its high level of complexity. The process involves multiple interconnected steps, ranging from cisplatin absorption to its interaction with the cellular antioxidant defense system, nuclear DNA, mitochondria, and the cytokine cascade. Each of these interactions contributes to the overall pathophysiology of ototoxicity and is closely interrelated. Based on these, various hypotheses and conclusions were outlined, and we tried to analyze them as broadly as possible. Knowledge of these mechanisms has given rise to promising avenues and otoprotection strategies to combat ototoxicity. Although there is only one drug approved by the FDA (Food and Drug Administration), there are numerous drugs that target the mechanisms presented, but that need more evidence to be able to be used safely. In addition to these, the role of the multidisciplinary team should not be neglected and protocols should be established for periodic follow-up of patients treated with cisplatin to prevent hearing loss. This narrative review aims to point out all the aspects presented, based on the analysis of the literature and the conclusions drawn over time. We have selected the articles of interest and analyzed the studies that have obtained promising results to bring an overview of how cisplatin acts at the cochlear level, what can be done to combat these mechanisms, what solutions exist now and how we can prevent hearing loss.


  • Open Access

    Targeting Pathways in Neuroblastoma: Advances in Treatment Strategies and Clinical Outcomes

    by Diana Benchia, Ovidiu Daniel Bîcă, Ioan Sârbu, Bogdan Savu, Diana Farcaș, Ingrith Miron, Anca Lavinia Postolache, Elena Cojocaru, Olivier Abbo, Carmen Iulia Ciongradi

    Neuroblastoma (NB) is a childhood cancer originating from neural crest cells of the sympathetic nervous system. Despite the advances in multimodal therapy, the treatment of high-risk NB remains challenging. The present review outlines several evidence-related insights into the molecular mechanisms of NB pathogenesis, focusing on genetic drivers (e.g., MYCN amplification) and disrupted signaling pathways (PI3K/Akt/mTOR; Notch; Jak2/STAT3), as well as on the tumor microenvironment’s role in progression and resistance. The authors highlight current and emerging therapeutic strategies, including molecularly targeted agents; immunotherapies; and differentiation approaches under investigation. The complexity and heterogeneity of NB underscores the need for continued translational research and for combined strategies aimed at improving outcomes for affected children, highlighting the need for integration of molecular profiling and precision medicine to guide treatment.


  • Open Access

    Pediatric COVID-19 and Diabetes: An Investigation into the Intersection of Two Pandemics

    by Silvia Fotea, Cristina Mihaela Ghiciuc, Gabriela Stefanescu, Anca Lavinia Cianga, Cristina Maria Mihai, Ancuta Lupu, Lacramioara Ionela Butnariu, Iuliana Magdalena Starcea, Delia Lidia Salaru, Adriana Mocanu, et al.

    Coronavirus disease 2019 (COVID-19) is a complex infectious disease caused by the SARS-CoV-2 virus, and it currently represents a worldwide public health emergency. The pediatric population is less prone to develop severe COVID-19 infection, but children presenting underlying medical conditions, such as diabetes mellitus, are thought to be at increased risk of developing more severe forms of COVID-19. Diabetic children face new challenges when infected with SARS-CoV-2. On one hand, the glycemic values become substantially more difficult to manage as COVID-19 is a predisposing factor for hyperglycemia. On the other hand, alongside other risk factors, high glycemic values are incriminated in modulating immune and inflammatory responses, leading to potentially severe COVID-19 cases in the pediatric population. Also, there are hypotheses of SARS-CoV-2 being diabetogenic itself, but this information is still to be confirmed. Furthermore, it is reported that there was a noticeable increase in the number of cases of new-onset type 2 diabetes among the pediatric population, and the complications in these patients with COVID-19 include the risk of developing autoimmune diseases under the influence of stress. Additionally, children with diabetes mellitus are confronted with lifestyle changes dictated by the pandemic, which can potentially lead to the onset or exacerbation of a potential underlying anxiety disorder or depression. Since the literature contains a series of unknowns related to the impact of COVID-19 in both types of diabetes in children, the purpose of our work is to bring together the data obtained so far and to identify potential knowledge gaps and areas for future investigation regarding COVID-19 and the onset of diabetes type 1 or type 2 among the pediatric population.


  • Open Access

    Helicobacter pylori Infection in Children: A Possible Reason for Headache?

    by Ancuta Lupu, Cristina Gavrilovici, Vasile Valeriu Lupu, Anca Lavinia Cianga, Andrei Tudor Cernomaz, Iuliana Magdalena Starcea, Cristina Maria Mihai, Elena Tarca, Adriana Mocanu, Silvia Fotea

    (1) Background: The correlation between infection with Helicobacter pylori (H. pylori) and headache has been argued and explored for a long time, but a clear association between the simultaneous presence of the two in children has not been established yet. In this study, we aimed to explore this relationship in children from the Northeast region of Romania. (2) Methods: A retrospective study exploring the correlation between children having H. pylori infection and headache or migraine was conducted on a batch of 1757 children, hospitalized over 3 years in a pediatric gastroenterology department in Northeast Romania. (3) Results: A total of 130 children of both sexes had headache. From 130 children, 54 children (41.5%) also presented H. pylori infection. A significant association between headache and H. pylori infection (χ2; p < 0.01) was noticed. (4) Conclusions: More studies are needed on this relationship, and we emphasize the importance of further analyses, as they present great clinical importance for both prompt diagnosis and treatment.


  • Open Access

    Pitfalls of Thrombotic Microangiopathies in Children: Two Case Reports and Literature Review

    by Adriana Mocanu, Roxana Alexandra Bogos, Tudor Ilie Lazaruc, Anca Lavinia Cianga, Vasile Valeriu Lupu, Ileana Ioniuc, Mirabela Alecsa, Ancuta Lupu, Anca Viorica Ivanov, Ingrith Crenguta Miron, et al.

    Thrombotic microangiopathy can present itself in the form of several clinical entities, representing a real challenge for diagnosis and treatment in pediatric practice. Our article aims to explore the evolution of two rare cases of pediatric thrombotic thrombocytopenic purpura (TTP) and atypical hemolytic uremic syndrome (aHUS) with extremely similar clinical pictures, which, coincidentally, presented at approximately the same time in our hospital. These cases and our literature review demonstrate the multiple facets of thrombotic microangiopathy, which can produce various determinations and salient manifestations even among the pediatric population. TTP and aHUS may represent genuine diagnostic pitfalls through the overlap of their clinical and biological findings, although they develop through fundamentally different mechanisms that require different therapeutic approaches. As a novelty, we underline that COVID-19 infection cannot be excluded as potential trigger for TTP and aHUS in our patients and we predict that other reports of such an association will follow, raising a complex question of COVID-19’s implication in the occurrence and evolution of thrombotic microangiopathies. On this matter, we conducted literature research that resulted in 15 cases of COVID-19 pediatric infections associated with either TTP or aHUS. Taking into consideration the morbidity associated with TTP and aHUS, an elaborate differential diagnosis and prompt intervention are of the essence.


  • Open Access

    Epidemiological Characteristics of Helicobacter pylori Infection in Children in Northeast Romania

    by Ancuta Lupu, Ingrith Crenguta Miron, Andrei Tudor Cernomaz, Cristina Gavrilovici, Vasile Valeriu Lupu, Iuliana Magdalena Starcea, Anca Lavinia Cianga, Bogdan Stana, Elena Tarca, Silvia Fotea

    (1) Background: Although gastritis has been associated with multiple etiologies, in pediatrics the main etiology is idiopathic. Many studies have reported mild-to-severe gastritis Helicobacter pylori (H. pylori) as an etiological factor. We evaluated the distribution of the infection with H. pylori by age, gender and place of living; (2) Methods: A retrospective study was conducted over a period of 3 years, over a cohort of 1757 patients of both sexes, aged between 1 and 18 years, admitted to a regional gastroenterology center in Iasi, Romania, with clinical signs of gastritis which underwent upper gastrointestinal endoscopy. The research was based on the analysis of data from patient observation charts and hospital discharge tickets, as well as endoscopy result registers; (3) Results: Out of the 1757 children, in 30.8% of cases the H. pylori infection was present. Out of them, 26.8% were males and 73.2% females. The average age of children with an H. pylori infection was higher (14.1 + 2.8 DS), compared with children without H. pylori (12.8 + 3.7 SD), an average difference of 1.3 years (95% confidence interval 0.96 to 1.66; p < 0.001). By place of living, children with H. pylori infection were from urban areas at 24.7% and from rural areas at 75.3%; (4) Conclusions: H. pylori infection incidence is still high in children, especially in teenagers, so extensive prevention and treatment programs are needed.


  • Open Access

    Diagnostic Pitfalls in Guillain–Barré Syndrome: Case Report and Literature Review

    by Vasile Valeriu Lupu, Ingrith Miron, Anca Lavinia Cianga, Cristina Gavrilovici, Ioana Grigore, Alexandru Gabriel David, Leonard Iosif Pertea, Ecaterina Grigore, Diana Elena David, Ancuta Lupu

    Guillain–Barré syndrome (GBS) represents a group of acute immune-mediated polyradiculoneuropathies that is usually characterized by symmetrical limb weakness and areflexia. GBS can also lead to atypical clinical findings, which may lead to confusion and errors in the diagnosis. In this report, we describe a case of Guillain–Barré syndrome in a 7-year-old child who presented with neck stiffness, headache and vomiting mimicking acute meningoencephalitis, arthritis and myositis. Symptoms of ascending paralysis developed subsequently. Clearly, the atypical presentation of GBS is a significant dilemma for pediatricians and may lead to delays in diagnosis and treatment.


  • Open Access

    The Prevalence of Liver Cytolysis in Children with Helicobacter pylori Infection

    by Ancuta Lupu, Ingrith Crenguta Miron, Anca Lavinia Cianga, Andrei Tudor Cernomaz, Vasile Valeriu Lupu, Cristina Gavrilovici, Iuliana Magdalena Stârcea, Elena Tarca, Dragos Catalin Ghica, Silvia Fotea

    (1) Background: The relationship between Helicobacter pylori (H. pylori) infection and liver disease has been discussed for many years, but the association between the infection and liver cytolysis in children has been insufficiently explored. In our study, we evaluate this relationship in a pediatric population from the northeast of Romania. (2) Methods: A retrospective study of children with H. pylori infection and liver cytolysis was conducted on a group of 1757 children, admitted to a pediatric gastroenterology regional center in northeast Romania over 3 years. (3) Results: Liver cytolysis syndrome was present in 112 children of both sexes. Of the 112 children, 20 children (17.9%) also had H. pylori infection. In the statistical analysis, we noted a significant association between liver cytolysis syndrome and H. pylori infection (χ2; p < 0.001). (4) Conclusions: This relationship requires further in-depth studies that also consider certain parameters that may influence the results of these correlations. In addition, we point out the need for further analyses evaluating, in terms of the histopathological changes in each liver disease, the efficacy of H. pylori eradication.